157 related articles for article (PubMed ID: 16627626)
1. Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis.
Zhang J; Liu Q; Chen Q; Liu NQ; Li FL; Lu ZB; Qin C; Zhu H; Huang YY; He W; Zhao BL
FASEB J; 2006 Jun; 20(8):1212-4. PubMed ID: 16627626
[TBL] [Abstract][Full Text] [Related]
2. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells.
Zhang J; Mori A; Chen Q; Zhao B
Neuroscience; 2006 Nov; 143(1):63-72. PubMed ID: 16962711
[TBL] [Abstract][Full Text] [Related]
3. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF
Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877
[TBL] [Abstract][Full Text] [Related]
4. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
[TBL] [Abstract][Full Text] [Related]
5. Metals and amyloid-beta in Alzheimer's disease.
Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
[TBL] [Abstract][Full Text] [Related]
6. A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease.
Dingwall C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):571-3. PubMed ID: 17511654
[TBL] [Abstract][Full Text] [Related]
7. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
Mousavi M; Hellström-Lindahl E
Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
[TBL] [Abstract][Full Text] [Related]
9. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
[TBL] [Abstract][Full Text] [Related]
10. Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice.
Steffen J; Krohn M; Schwitlick C; Brüning T; Paarmann K; Pietrzik CU; Biverstål H; Jansone B; Langer O; Pahnke J
Acta Neuropathol Commun; 2017 Jun; 5(1):49. PubMed ID: 28637503
[TBL] [Abstract][Full Text] [Related]
11. Role of copper and the copper-related protein CUTA in mediating APP processing and Aβ generation.
Hou P; Liu G; Zhao Y; Shi Z; Zheng Q; Bu G; Xu H; Zhang YW
Neurobiol Aging; 2015 Mar; 36(3):1310-5. PubMed ID: 25557959
[TBL] [Abstract][Full Text] [Related]
12. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
Hashimoto Y; Matsuoka M
J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
[TBL] [Abstract][Full Text] [Related]
13. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
[TBL] [Abstract][Full Text] [Related]
14. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.
Schäfer S; Pajonk FG; Multhaup G; Bayer TA
J Mol Med (Berl); 2007 Apr; 85(4):405-13. PubMed ID: 17211610
[TBL] [Abstract][Full Text] [Related]
15. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
16. The amyloid paradox: amyloid-beta-metal complexes can be neurotoxic and neuroprotective.
Bishop GM; Robinson SR
Brain Pathol; 2004 Oct; 14(4):448-52. PubMed ID: 15605992
[TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw).
Nordberg A; Hellström-Lindahl E; Lee M; Johnson M; Mousavi M; Hall R; Perry E; Bednar I; Court J
J Neurochem; 2002 May; 81(3):655-8. PubMed ID: 12065674
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
[TBL] [Abstract][Full Text] [Related]
19. Effects of nicotine on APP secretion and Abeta- or CT(105)-induced toxicity.
Seo J; Kim S; Kim H; Park CH; Jeong S; Lee J; Choi SH; Chang K; Rah J; Koo J; Kim E; Suh Y
Biol Psychiatry; 2001 Feb; 49(3):240-7. PubMed ID: 11230875
[TBL] [Abstract][Full Text] [Related]
20. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
